The data-driven design of the CS EDGE™ helps optimize implant fit while preserving bone. AUSTIN, Texas--(BUSINESS WIRE)--DJO, LLC (“DJO” or the “Company”), a leading global provider of medical technologies to get...
Avenu's Percutaneous Fistula Creation Technology Will Strengthen the Medtronic Peripheral Vascular Access Portfolio and Reinforce Medtronic's Commitment to Improving Outcomes for Patients with End-Stage Renal Disease DUBLIN, Sept. 30, 2020 /PRNewswire/ -- Medtronic plc...
Kalamazoo, Michigan, Sept. 29, 2020 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK) announced today that Stryker B.V., an indirect, wholly owned subsidiary of Stryker, has extended the offering period of its...
SALT LAKE CITY, Sept. 14, 2020 /PRNewswire/ — Stratus™ Medical, a company focused on advancing radiofrequency ablation (RFA) treatment for chronic pain, announced today that the United States Patent and Trademark Office...
DUBLIN, Sept. 29, 2020 /PRNewswire/ -- Medtronic plc (the "Company") (NYSE:MDT) today announced that its wholly-owned subsidiary Medtronic Global Holdings S.C.A. ("Medtronic Luxco") has closed a registered public offering (the "Offering") of €1,250,000,000 principal...
Cordera™ Hip System with optional patient-specific instrumentation and personalized surgical plan joins the 3D Conformis Hip System as the latest hip technology from Conformis. BILLERICA, Mass., Sept. 29, 2020 (GLOBE NEWSWIRE)...
Intramedullary Nailing System Provides Strong, Stable and Efficient Tool Designed to Promote Accurate Nail Insertion. MAHWAH, N.J.--(BUSINESS WIRE)--Stryker’s Trauma & Extremities division today announced the launch of its T2® ICF Intramedullary nailing...
PESSAC, France--(BUSINESS WIRE)--Hyprevention has raised new financing to support the V-STRUT© Vertebral Implant product. The financing will be used to execute the commercialization plans for the US spinal fracture market....
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, announces that it has agreed to acquire the Extremity Orthopaedics business of Integra LifeSciences Holdings Corporation (NASDAQ:IART) for $240 million. The acquisition...
Closed non-brokered and oversubscribed Private Placements for total gross proceeds of $2.6 million, including $353,000 from management and Board members Preclinical results confirmed safety of Ortho-R and statistical significance over standard of...